GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,245,000 | +48.1% | 384,168 | +28.9% | 0.08% | +47.1% |
| Q3 2021 | $7,594,000 | +73.3% | 298,051 | +138.3% | 0.05% | +70.0% |
| Q2 2021 | $4,381,000 | -18.9% | 125,095 | -5.6% | 0.03% | -28.6% |
| Q1 2021 | $5,401,000 | -24.2% | 132,540 | -19.4% | 0.04% | -32.3% |
| Q4 2020 | $7,125,000 | +1259.7% | 164,520 | +1630.5% | 0.06% | +1140.0% |
| Q3 2020 | $524,000 | +16.7% | 9,507 | -66.4% | 0.01% | -50.0% |
| Q1 2016 | $449,000 | – | 28,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |